DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,263,000 | -79.4% | 211,448 | -61.9% | 0.01% | -60.0% |
| Q2 2021 | $20,710,000 | +118.1% | 554,936 | +49.4% | 0.03% | +3.4% |
| Q1 2021 | $9,497,000 | +18.0% | 371,440 | +1.7% | 0.03% | +16.0% |
| Q4 2020 | $8,045,000 | +62.8% | 365,191 | +33.0% | 0.02% | +38.9% |
| Q3 2020 | $4,941,000 | -57.2% | 274,659 | -39.6% | 0.02% | -21.7% |
| Q2 2020 | $11,554,000 | +31.7% | 454,832 | -4.8% | 0.02% | +4.5% |
| Q1 2020 | $8,776,000 | – | 477,744 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |